Efficacy and Safety of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study

Guanglei Chen, Xi Gu, Xu Zhang, Xiaopeng Yu, Yu Zhang, Jinqi Xue, Ailin Li, Yi Zhao, Guijin He, Meiyue Tang, Fei Xing, Jianqiao Yin, Xiaobo Bian, Ye Han, Shuo Cao, Chao Liu, Xiaofan Jiang, Keliang Zhang, Yan Xia, Huajun Li, Nan Niu, Caigang Liu
doi: https://doi.org/10.1101/2023.08.14.23294091

Article usage

Article usage: August 2023 to February 2025

AbstractFullPdf
Aug 20232891142
Sep 202381714
Oct 202339513
Nov 20232648
Dec 202339518
Jan 20241305
Feb 20246017
Mar 202422710
Apr 20241139
May 20241527
Jun 202422912
Jul 202415314
Aug 202425118
Sep 202417210
Oct 20244210
Nov 202418014
Dec 202413214
Jan 202531514
Feb 20251557
Back to top
Posted August 17, 2023.
Download PDF
Email
Efficacy and Safety of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study
Guanglei Chen, Xi Gu, Xu Zhang, Xiaopeng Yu, Yu Zhang, Jinqi Xue, Ailin Li, Yi Zhao, Guijin He, Meiyue Tang, Fei Xing, Jianqiao Yin, Xiaobo Bian, Ye Han, Shuo Cao, Chao Liu, Xiaofan Jiang, Keliang Zhang, Yan Xia, Huajun Li, Nan Niu, Caigang Liu
medRxiv 2023.08.14.23294091; doi: https://doi.org/10.1101/2023.08.14.23294091
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area